Market Analysis: Global Respiratory Diagnostics Market
The Global Respiratory Diagnostics market accounted to USD 6.12 billion in 2016 growing at a CAGR of 7,5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Market Definition: Global Respiratory Diagnostics Market
Respiratory diseases are the diseases which affects are constantly raising due to air pollutions. Asthma, chronic obstructive pulmonary disease, chronic bronchitis, pulmonary edema, lung cancer, emphysema and cystic fibrosis are some of the major respiratory diseases. Due to prevalence in respiratory diseases, respiratory diagnostics market is growing rapidly.
Major market drivers and restraints:
- Increasing prevalence of respiratory diseases
- Technological advancement in respiratory diagnostic testing
- Growth in geriatric population with respiratory disorders
- Increase in the demand for respiratory devices in private hospitals and clinics
- High prevalence of tobacco smoking
- Urbanization and growing pollution levels
- High price associated with COPD diagnosis and testing
- Strict regulatory requirements
- Reimbursement concerns
Market Segmentation: Global Respiratory Diagnostics Market
The global respiratory diagnostics market is segmented by product and service into instruments & devices, assays & reagents and services & software.
By test type the market is segmented into mechanical tests, OSA diagnostic tests, other test types, imaging tests, traditional diagnostic tests and molecular diagnostic tests. Mechanical tests are further sub segmented into pulmonary function tests. Pulmonary function tests are again sub segmented into spirometry and peak flow test. Imaging Tests are further sub segmented into X-Ray, computed tomography, magnetic resonance imaging (MRI), positron emission tomography (PET) and other. Traditional diagnostic tests are further sub segmented into immunodiagnostics, biochemical characterization and microscopy. Molecular diagnostic tests are further sub segmented into PCR, nucleic acid amplification test, in situ hybridization, DNA sequencing & next-generation sequencing (NGS), microarrays and other.
On the basis of disease the market is segmented into tuberculosis, asthma, lung cancer, chronic obstructive pulmonary disease and other.
By end user the market is segmented into hospital, clinical laboratories, reference laboratories and physician offices.
On the basis of geography, respiratory diagnostics market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.
Competitive Analysis: Global Respiratory Diagnostics Market
The respiratory diagnostics market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of respiratory diagnostics market for global, Europe, North America, Asia Pacific and South America.
Major Market Competitors: Global Respiratory Diagnostics Market
Some of the major players operating in respiratory diagnostics market are Koninklijke Philips N.V., BD, Abbott, Thermo Fisher Scientific Inc., Medtronic, NIHON KOHDEN CORPORATION, General Electric Company, Smiths Group plc, Drägerwerk AG & Co. KGaA, Bio-Rad Laboratories, Inc., 3M, AstraZeneca, GlaxoSmithKline plc, ResMed, Haier Inc., MGC Diagnostics Corporation, CARESTREAM MEDICAL, Masimo, bioMérieux SA, British Diagnostics and COSMED among others.
Research Methodology: Global Respiratory Diagnostics Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or Drop down your inquiry.
Demand Side Primary Contributors: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side Primary Contributors: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.